You are here
Consultations
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Trove at the National Library of Australia has information on archived TGA consultations and reviews.
Filters
Status
Categories
- Advertising (2) Apply Advertising filter
- Australian Register of Therapeutic Goods (ARTG) (1) Apply Australian Register of Therapeutic Goods (ARTG) filter
- Remove Biologicals filter Biologicals (2)
- Complementary medicines (7) Apply Complementary medicines filter
- Remove Cosmetics filter Cosmetics (0)
- Fees/Payments (1) Apply Fees/Payments filter
- Import/Export (1) Apply Import/Export filter
- Labelling/Packaging (1) Apply Labelling/Packaging filter
- Legislation (3) Apply Legislation filter
- Listed medicines (2) Apply Listed medicines filter
- Manufacturing (1) Apply Manufacturing filter
- Remove Medical devices/IVDs filter Medical devices/IVDs (55)
- Medical devices safety (1) Apply Medical devices safety filter
- Remove Medicinal cannabis filter Medicinal cannabis (1)
- Medicines (2) Apply Medicines filter
- Medicines safety (1) Apply Medicines safety filter
- OTC medicines (12) Apply OTC medicines filter
- Other therapeutic goods (1) Apply Other therapeutic goods filter
- Remove Prescription medicines filter Prescription medicines (7)
- Scheduling (56) Apply Scheduling filter
- Remove Therapeutic Goods Administration (TGA) filter Therapeutic Goods Administration (TGA) (2)
- Therapeutic goods regulation (2) Apply Therapeutic goods regulation filter
- (-) Remove Biologicals filter Biologicals
- (-) Remove Cosmetics filter Cosmetics
- (-) Remove Medicinal cannabis filter Medicinal cannabis
- (-) Remove Prescription medicines filter Prescription medicines
- (-) Remove Therapeutic Goods Administration (TGA) filter Therapeutic Goods Administration (TGA)
- (-) Remove Medical devices/IVDs filter Medical devices/IVDs
Accelerated assessment of medical devices - Priority Review pathway - Implementation
Closed on 11 January 2017
Software as a Medical Device (SaMD): Clinical Evaluation
Closed on 2 December 2016
Draft clinical evidence guidelines - Medical devices
Closed on 10 June 2016
Software as a Medical Device (IMDRF Working Group)
Closed on 27 May 2015
Proposed performance requirements and risk mitigation strategies for HIV tests
Closed on 30 January 2015
Software as a medical device (IMDRF working group)
Closed on 31 May 2014
Supply of in vitro diagnostic devices for self-testing (home testing) for the presence of human immunodeficiency virus in Australia
Closed on 6 May 2014
Proposed amendments to the new regulatory framework for In Vitro Diagnostic medical devices (IVDs)
Closed on 7 June 2013
Regulation Impact Statement: Changes to premarket assessment requirements for medical devices
Closed on 3 June 2013
Reforms in the medical devices regulatory framework
Closed on 17 December 2010